Emergent Biosolutions, formerly Cangene bioPharma, is a contract manufacturer providing fill-finish services to pharmaceutical and biotechnology companies. Services include clinical manufacturing, commercial manufacturing, lyophilization, product testing and stability testing. The company currently produces 20 commercial products and since 1990 has contributed to the development and production of more than 200 clinical products. Emergent Biosolutions has been inspected and approved by regulatory agencies in the US, Europe and Japan.